Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
2002 1
2003 3
2004 3
2007 1
2008 3
2009 1
2010 3
2013 1
2015 1
2016 1
2017 1
2024 2
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Altering heparan sulfate suppresses cell abnormalities and neuron loss in Drosophila presenilin model of Alzheimer Disease.
Schultheis N, Connell A, Kapral A, Becker RJ, Mueller R, Shah S, O'Donnell M, Roseman M, Swanson L, DeGuara S, Wang W, Yin F, Saini T, Weiss RJ, Selleck SB. Schultheis N, et al. Among authors: mueller r. iScience. 2024 Jul 2;27(7):110256. doi: 10.1016/j.isci.2024.110256. eCollection 2024 Jul 19. iScience. 2024. PMID: 39109174 Free PMC article.
Heparan sulfate modified proteins affect cellular processes central to neurodegeneration and modulate presenilin function.
Schultheis N, Connell A, Kapral A, Becker RJ, Mueller R, Shah S, O'Donnell M, Roseman M, Wang W, Yin F, Weiss R, Selleck SB. Schultheis N, et al. Among authors: mueller r. bioRxiv [Preprint]. 2024 Jan 24:2024.01.23.576895. doi: 10.1101/2024.01.23.576895. bioRxiv. 2024. Update in: iScience. 2024 Jul 02;27(7):110256. doi: 10.1016/j.isci.2024.110256. PMID: 38328107 Free PMC article. Updated. Preprint.
Liraglutide and Renal Outcomes in Type 2 Diabetes.
Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators. Mann JFE, et al. N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011. N Engl J Med. 2017. PMID: 28854085 Free article. Clinical Trial.
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Marso SP, et al. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13. N Engl J Med. 2016. PMID: 27295427 Free PMC article. Clinical Trial.
Shipboard trials of an ozone-based ballast water treatment system.
Wright DA, Gensemer RW, Mitchelmore CL, Stubblefield WA, van Genderen E, Dawson R, Orano-Dawson CE, Bearr JS, Mueller RA, Cooper WJ. Wright DA, et al. Among authors: mueller ra. Mar Pollut Bull. 2010 Sep;60(9):1571-83. doi: 10.1016/j.marpolbul.2010.04.010. Epub 2010 May 18. Mar Pollut Bull. 2010. PMID: 20483433
Skin dose study of chest wall treatment with tomotherapy.
Javedan K, Zhang G, Mueller R, Harris E, Berk L, Forster K. Javedan K, et al. Among authors: mueller r. Jpn J Radiol. 2009 Nov;27(9):355-62. doi: 10.1007/s11604-009-0357-9. Epub 2009 Nov 27. Jpn J Radiol. 2009. PMID: 19943146
22 results